Arthrex® AR-7240Recalls & reported problems

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00888867041783), received between Sep 19, 2017 and Sep 19, 2017 — classified as 1 injury.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.

Most reported problems

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

• InjurySep 19, 2017Adverse Event Without Identified Device or Use Problem

  THE DISTRIBUTOR REPORTED, PATIENT REACTION IN DATE CHRONOLOGY ORDER: (B)(6) 2017 - TENOPLASTY USING THE PARS SYSTEM. (B)(6) 2017- AFTER 1 MONTH AND 23 POSTOPERATIVE DAYS PRESENTED A REACTION PROCESS IN INCISION WITH DEHISCENCE IN THE INCISION, PATIENT DENIES TRAUMA OR EFFORT, USING ARTICULATED VACOPED BOOT. (B)(6) 2017- 2 MONTHS AND 14 DAYS PO- REACTION PROCESS IN THE INCISION WITH REMOVAL OF THE WHITE THREAD, IN USE OF THE BOOT TYPE ARTICULATED VACOPED. (B)(6) 2017- REACTION PROCESS OF THE INCISION WITH REMOVAL OF THE WHITE / BLACK WIRE, IN USE OF AN ARTICULATED VACOPED BOOT. (B)(6) 2017- 3 MONTHS PO- REACTION PROCESS OF THE INCISION WITH REMOVAL OF THE BLUE WIRE, WITHOUT USE OF IMMOBILIZATION. THREE MONTHS AND 10 DAYS PO- SILVERCEL CURATIVE USE. IMPROVEMENT OF APPEARANCE, WITHOUT PURULENT DISCHARGE, ONLY BLOODY. NO PAIN AND TENDON INTACT WITH GOOD FUNCTION, PATIENT DOING LOW-IMPACT DAILY ACTIVITIES. PATIENT IS SEEN BY THE DOCTOR 3 TIMES A WEEK. IT IS PRESENTING A NEW REACTIONAL AREA, NOW OF THE DISTAL WIRES, STILL WITH REACTION PROCESS. THE DISTAL SUTURES HAVE NOT YET LEFT.

  Patient problems: Wound Dehiscence

  MAUDE report 6875392 ↗